Synthesis, Molecular Docking and Preliminary Antileukemic Activity of 4‐Methoxybenzyl Derivatives Bearing Imidazo[2,1‐
<i>b</i>
][1,3,4]thiadiazole
作者:B. Choodamani、Karla G. Cano Hernandez、Sujeet Kumar、Ann Maria Tony、Austre Y. Schiaffino Bustamante、Renato J. Aguilera、Dominique Schols、C. Gopi Mohan、Subhas S. Karki
DOI:10.1002/cbdv.202000800
日期:2021.2
In this study, we synthesized 22 compounds in a series with various substitution on imidazo[2,1- b ][1,3,4]thiadiazoles. The potential cytotoxic activity of these compounds investigated in leukemia cell lines by Differential Nuclear Staining (DNS). Our results identify two compounds 2-(4-methoxybenzyl)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl thiocyanate and 6-(4-chlorophenyl)
在这项研究中,我们合成了 22 种在咪唑并[2,1-b][1,3,4]噻二唑上具有不同取代基的化合物。通过差异核染色 (DNS) 在白血病细胞系中研究了这些化合物的潜在细胞毒活性。我们的结果确定了两种化合物 2-(4-甲氧基苄基)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl thiocyanate 和6-(4-氯苯基)-2-(4'-甲氧基苄基)咪唑并[2,1-b][1,3,4]噻二唑-5-甲醛对鼠白血病细胞(L1210)的细胞毒性作用最强,人 T 淋巴细胞 (CEM) 和人子宫颈癌细胞 (HeLa),IC 50 值介于 0.79 至 1.6 μM 之间。结果表明化合物2-(4-甲氧基苄基)-6-(2-氧代-2H-色烯-3-基)咪唑并[2,1-b][1,3, 4]thidiazol-5-yl thiocyanate